Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice - PubMed (original) (raw)

Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice

E Conneally et al. Proc Natl Acad Sci U S A. 1997.

Abstract

Human hematopoiesis originates in a population of stem cells with transplantable lympho-myeloid reconstituting potential, but a method for quantitating such cells has not been available. We now describe a simple assay that meets this need. It is based on the ability of sublethally irradiated immunodeficient nonobese diabetic-scid/scid (NOD/SCID) mice to be engrafted by intravenously injected human hematopoietic cells and uses limiting dilution analysis to measure the frequency of human cells that produce both CD34(-)CD19(+) (B-lymphoid) and CD34(+) (myeloid) colony-forming cell progeny in the marrow of such recipients 6 to 8 weeks post-transplant. Human cord blood (CB) contains approximately 5 of these competitive repopulating units (CRU) per ml that have a similar distribution between the CD38(-) and CD38(+) subsets of CD34(+) CB cells as long-term culture-initiating cells (LTC-IC) (4:1 vs. 2:1). Incubation of purified CD34(+)CD38(-) human CB cells in serum-free medium containing flt-3 ligand, Steel factor, interleukin 3, interleukin 6, and granulocyte colony-stimulating factor for 5-8 days resulted in a 100-fold expansion of colony-forming cells, a 4-fold expansion of LTC-IC, and a 2-fold (but significant, P < 0.02) increase in CRU. The culture-derived CRU, like the original CB CRU, generated pluripotent, erythroid, granulopoietic, megakaryopoietic, and pre-B cell progeny upon transplantation into NOD/SCID mice. These findings demonstrate an equivalent phenotypic heterogeneity amongst human CB cells detectable as CRU and LTC-IC. In addition, their similarly modest response to stimulation by a combination of cytokines that extensively amplify LTC-IC from normal adult marrow underscores the importance of ontogeny-dependent changes in human hematopoietic stem cell proliferation and self-renewal.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Comparison of FACS profiles of marrow cells from NOD/SCID mice transplanted 6 and 8 weeks previously with 300 CD34+CD38− cells (A and B) (i.e., at limiting dilution) and 3 × 103 CD34+CD38− cells (C) from the same original CB sample. In A the cells were stained with an irrelevant (control) isotype-matched mouse IgG. In B and C, the cells were stained with anti-human CD34–CY5 (cyanine-5-succinimidyl) and anti-human CD19–PE. Evidence of human cells of all three phenotypes examined in these analyses is seen in both mice (B and C).

Similar articles

Cited by

References

    1. Szilvassy S J, Humphries R K, Lansdorp P M, Eaves A C, Eaves C J. Proc Natl Acad Sci USA. 1990;87:8736–8740. - PMC - PubMed
    1. Fraser C C, Szilvassy S J, Eaves C J, Humphries R K. Proc Natl Acad Sci USA. 1992;89:1968–1972. - PMC - PubMed
    1. Rebel V I, Dragowska W, Eaves C J, Humphries R K, Lansdorp P M. Blood. 1994;83:128–136. - PubMed
    1. Harrison D E, Jordan C T, Zhong R K, Astle C M. Exp Hematol. 1993;21:206–219. - PubMed
    1. Trevisan M, Yan X, Iscove N N. Blood. 1996;88:4149–4158. - PubMed

Publication types

MeSH terms

LinkOut - more resources